Skip to main content
News

The Dutch company MIMETAS expanded its license to the HUB Organoid Technology to include all organs – Drug Discovery & Development

By May 16, 2022No Comments
632 organoid picture 2236

632 organoid picture 2236MIMETAS, a global leader in Organ-on-a-Chip models and technology and headquartered in the Netherlands (Europe), announces  that it has expanded its license to the HUB Organoid Technology to include all organs. The license covers organoid technology developed by Professor Hans Clevers, a pioneer in adult stem cells.

 

{iframe}https://www.pharmaindustrial-india.com/news/the-dutch-company-mimetas-expanded-its-license-to-the-hub-organoid-technology-to-include-all-organs{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.